However, another study reported that ERCC1 expression was not prognostic of tumor recurrence and overall survival in patients with advanced NSCLC.12,13 The inconsistency of these findings could be explained by differences in ethnicities, number of included cases and study design. The gene discussed is ERCC1; the disease is neoplasm.